Nephron Pharmaceuticals Corp — Form D

Nephron Pharmaceuticals Corp of ORLANDO, FL, a company, filed a Form D exempt-offering notice with the SEC on 2014-08-21. The offering totals $75.0M, of which $75.0M was reported sold. Industry: Business Services.

Offering

• Filed: 2014-08-21
• Form: D
• Accession: 0001617435-14-000001
• Industry: Business Services
• Exemptions: 06b
• Total offering: $75.0M
• Amount sold: $75.0M
• Minimum investment: $475K
• Investors: 8
• Date of first sale: 2014-08-07
• Security types: debt
• Revenue range: Over $100,000,000
• SEC file number: 021-223374

Issuer

• Name: Nephron Pharmaceuticals Corp
• CIK: 0001617435
• Entity type: Corporation
• Jurisdiction: FLORIDA
• Address: 3855 ST. VALENTINE WAY Suite 1700, ORLANDO, FL, 32811
• Phone: 800-443-3414

Officers, directors & promoters (3)

More

• CIK 1617435 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search